459 results on '"Cancer treatment -- Forecasts and trends"'
Search Results
152. Immuno-Oncology Diagnostics: The Race for Biomarkers Market to 2024
153. Worldwide Immuno-Oncology Diagnostics Markets to 2024: The Race for Biomarkers
154. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024
155. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024 - ResearchAndMarkets.com
156. Global Immuno-Oncology Diagnostics Market Forecasts 2020-2024
157. DRGT Announces First Subject Dosed in a Phase I Clinical Trial of DRGT 45, a Novel Formulation of Abiraterone Acetate for Prostate Cancer
158. US and European Interventional Oncology Devices Market Assessment for Breast Cancer During the Forecast Period, 2016-2020
159. Xenetic Biosciences, Inc. Provides Business Outlook
160. Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma
161. Cervical Cancer Treatment Market is predicted to exhibit 6.5% CAGR from 2019 to 2023 | Market Segments, Dynamics, Size,Top Key Players, Current Trends, Supply and Demand
162. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape - ResearchAndMarkets.com
163. $74.9 Bn Blood and Bone Marrow Cancer Treatment Market, 2027
164. United States Breast Cancer Market and Competitive Landscape 2014-2019 & 2024
165. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape
166. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape - ResearchAndMarkets.com
167. Global Blood and Bone Marrow Cancer Treatment Market to 2027 by Indication, Therapy, Geography, Competitive Landscape
168. Ruth Bader Ginsburg makes first public appearance since completing cancer treatment
169. Rising Application of Systematic Therapeutics Delivery Systems to Accelerate the Growth of Global Radiation Therapy Market - TMR
170. Rising Application of Systematic Therapeutics Delivery Systems to Accelerate the Growth of Global Radiation Therapy Market - TMR
171. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024
172. Squamous Cell Carcinoma in the United States, 2019: The Market & Competitive Landscape, 2014 to 2024
173. Squamous Cell Carcinoma in the United States, 2019: The Market & Competitive Landscape, 2014 to 2024 - ResearchAndMarkets.com
174. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024 - ResearchAndMarkets.com
175. Squamous Cell Carcinomain the United States, 2019: The Market & Competitive Landscape, 2014 to 2024
176. The United States Basal Cell Carcinoma Market & Competitive Landscape: 2014-2019 & 2024
177. Global Novel Immuno-Oncology Biomarker Testing Market Report, 2019-2030 - Focus on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)
178. Global Novel Immuno-Oncology Biomarker Testing Market Report, 2019-2030 - Focus on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+) - ResearchAndMarkets.com
179. Novel Immuno-Oncology Biomarker Testing Market, 2019-2030
180. Embolization Particle Market Share Is Expected To Reach USD 1.9 Billion With a Lucrative CAGR of 9.6% Owing To Rising Usage Of Embolization Particle In Treatment Of Cancer Till 2023
181. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024)
182. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024) - ResearchAndMarkets.com
183. United States Renal Cell Carcinoma Market & Competitive Landscape Analysis (2014-2024)
184. Image Guided Radiotherapy Market to Boost at a CAGR of 15.8% Due to Rapid Development in Cancer Treatment During 2019-2023, Asserts MRFR
185. US Lung Cancer Market and Competitive Landscape - 2019
186. US Lung Cancer Market and Competitive Landscape - 2019 - ResearchAndMarkets.com
187. US Lung Cancer Market and Competitive Landscape - 2019
188. US Stomach Cancer Market and Competitive Landscape For 2019
189. US Bladder Cancer Market and Competitive Landscape, 2019
190. US Liver Cancer Hepatoma Market and Competitive Landscape During 2019
191. US Brain Cancer Market and Competitive Landscape Highlights, 2019
192. US Liver Cancer Hepatoma Market and Competitive Landscape During 2019 - ResearchAndMarkets.com
193. US Bladder Cancer Market and Competitive Landscape, 2019
194. US Stomach Cancer Market and Competitive Landscape For 2019
195. US Bladder Cancer Market and Competitive Landscape, 2019 - ResearchAndMarkets.com
196. US Stomach Cancer Market and Competitive Landscape For 2019 - ResearchAndMarkets.com
197. United States Ovarian Cancer Market and Competitive Landscape 2014-2018 & 2019-2024
198. United States Chronic Myeloid Leukemia Market and Competitive Landscape 2019-2024
199. United States Thyroid Cancer Market and Competitive Landscape 2019: Treatment Options, Pipeline Products, Epidemiology, Key Products Marketed, Market Valuations & Forecast, and Sales & Market Shares
200. US Brain Cancer Market and Competitive Landscape Highlights, 2019 - ResearchAndMarkets.com
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.